212 related articles for article (PubMed ID: 29984478)
1. Peristomal pyoderma gangrenosum: 12-year experience in a single tertiary referral centre.
Toh JWT; Young CJ; Rickard MJFX; Keshava A; Stewart P; Whiteley I
ANZ J Surg; 2018 Oct; 88(10):E693-E697. PubMed ID: 29984478
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.
Afifi L; Sanchez IM; Wallace MM; Braswell SF; Ortega-Loayza AG; Shinkai K
J Am Acad Dermatol; 2018 Jun; 78(6):1195-1204.e1. PubMed ID: 29288099
[TBL] [Abstract][Full Text] [Related]
3. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management.
Sheldon DG; Sawchuk LL; Kozarek RA; Thirlby RC
Arch Surg; 2000 May; 135(5):564-8; discussion 568-9. PubMed ID: 10807281
[TBL] [Abstract][Full Text] [Related]
4. Clinical treatment options for peristomal pyoderma gangrenosum.
Vujnovich A
Br J Nurs; 2005 Sep 8-21; 14(16):S4-8. PubMed ID: 16215501
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.
Barbosa NS; Tolkachjov SN; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT; Bridges AG; Wetter DA
J Am Acad Dermatol; 2016 Nov; 75(5):931-939. PubMed ID: 27473454
[TBL] [Abstract][Full Text] [Related]
6. Management of peristomal pyoderma gangrenosum.
Poritz LS; Lebo MA; Bobb AD; Ardell CM; Koltun WA
J Am Coll Surg; 2008 Feb; 206(2):311-5. PubMed ID: 18222385
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and treatment of peristomal pyoderma gangrenosum.
Hughes AP; Jackson JM; Callen JP
JAMA; 2000 Sep; 284(12):1546-8. PubMed ID: 11000649
[TBL] [Abstract][Full Text] [Related]
8. Management of peristomal pyoderma gangrenosum.
Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
[TBL] [Abstract][Full Text] [Related]
9. A novel topical therapy for resistant and early peristomal pyoderma gangrenosum.
Pearson WA; Prentice DA; Sinclair DL; Lim LY; Carville KJ
Int Wound J; 2019 Oct; 16(5):1136-1143. PubMed ID: 31298491
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for peristomal pyoderma gangrenosum complicating inflammatory bowel disease.
Wu XR; Mukewar S; Kiran RP; Remzi FH; Hammel J; Shen B
J Crohns Colitis; 2013 Jun; 7(5):e171-7. PubMed ID: 22959399
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
Wang J; Prenner J; Wang W; Sakuraba A; Hyman N; Dalal S; Hurst R; Cohen RD; Umanskiy K; Shogan BD; Alpert L; Rubin DT; Colwell J; Pekow J
Aliment Pharmacol Ther; 2020 Jun; 51(12):1365-1372. PubMed ID: 32383278
[TBL] [Abstract][Full Text] [Related]
12. [Pyoderma gangrenosum peristomal in ulcerative colitis; first report of a case in Mexico].
Vergara-Fernández O; Vega R; Morales-Olivera JM; Gamboa-Domínguez A; Uscanga L; Takahashi-Monrroy T
Rev Gastroenterol Mex; 2008; 73(2):89-92. PubMed ID: 19666253
[TBL] [Abstract][Full Text] [Related]
13. Peri-ileostomy pyoderma gangrenosum. Case report.
Cerdán-Santacruz C; Caparrós-Sanz MR; Lancharro-Bermúdez M; Mendoza-Hernández J L ; Cerdán-Miguel J
Rev Esp Enferm Dig; 2014 Apr; 106(4):285-8. PubMed ID: 25075661
[TBL] [Abstract][Full Text] [Related]
14. Peristomal pyoderma gangrenosum and inflammatory bowel disease.
Cairns BA; Herbst CA; Sartor BR; Briggaman RA; Koruda MJ
Arch Surg; 1994 Jul; 129(7):769-72. PubMed ID: 7912923
[TBL] [Abstract][Full Text] [Related]
15. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
[TBL] [Abstract][Full Text] [Related]
16. Topical therapy for peristomal pyoderma gangrenosum.
Nybaek H; Olsen AG; Karlsmark T; Jemec GB
J Cutan Med Surg; 2004; 8(4):220-3. PubMed ID: 16091998
[TBL] [Abstract][Full Text] [Related]
17. Parastomal pyoderma gangrenosum in inflammatory bowel disease.
Tjandra JJ; Hughes LE
Dis Colon Rectum; 1994 Sep; 37(9):938-42. PubMed ID: 8076495
[TBL] [Abstract][Full Text] [Related]
18. Topical tacrolimus in the management of peristomal pyoderma gangrenosum.
Lyon CC; Stapleton M; Smith AJ; Mendelsohn S; Beck MH; Griffiths CE
J Dermatolog Treat; 2001 Mar; 12(1):13-7. PubMed ID: 12171681
[TBL] [Abstract][Full Text] [Related]
19. Topical Management of Peristomal Pyoderma Gangrenosum: A Report of 3 Case Studies.
Toyoda T; Mitsuyama S; Nagao E; Abe F; Kimura M; Seido Y; Higuchi T
J Wound Ostomy Continence Nurs; 2021 Jul-Aug 01; 48(4):345-349. PubMed ID: 33951706
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
